Baidu
map

1+1>2:抗高血压药如何联用更合理?

2017-01-05 清风 华医网

抗高血压药物联合治疗的原则1.选择药代动力学和药效学上互补的药物①药代动力学主要考虑的是药物的体内过程,包括肝脏的代谢及肾脏的排泄;②药效学上互补主要是从药物的作用机理着手,作用机理不同的药物联合使用可以使降压效果增强。2.应避免联合使用降压原理相近的药物①临床上不主张把ACEI(血管紧张素转化酶抑制剂),ARB(血管紧张素II受体阻滞剂)及β受体阻滞剂两两联合应用;②ACEI与ARB作用机理是在

高血压药物联合治疗的原则

1.选择药代动力学和药效学上互补的药物

①药代动力学主要考虑的是药物的体内过程,包括肝脏的代谢及肾脏的排泄;

②药效学上互补主要是从药物的作用机理着手,作用机理不同的药物联合使用可以使降压效果增强。

2.应避免联合使用降压原理相近的药物

①临床上不主张把ACEI(血管紧张素转化酶抑制剂),ARB(血管紧张素II受体阻滞剂)及β受体阻滞剂两两联合应用;

②ACEI与ARB作用机理是在一系列的生理反应中阻断不同的环节,实际上是作用于一个生理系统;

③β受体阻滞剂的作用机理是通过肾素血管紧张素醛固酮系统,和ACEI、ARB类相近。

3.联合治疗应较单药治疗提高疗效,加强靶器官保护同时减少及抵消不良反应

4.长效和短效药物联合

①可提高患者对药物的依从性;

②此类联合可更好的控制平稳血压,利于对靶器官的保护。

5.简化治疗方法,尽可能降低费用

①根据患者的具体情况决定是否联合用药;

②患者需联合用药时,应该尽量选择较少的药物种类,并尽可能降低用药费用。

高血压药物联合使用的合理方案

1.利尿剂+ACEI/ARB 

利尿剂激活肾素-血管紧张素-醛固酮系统(RAAS),从而使作用于RAAS的ACEI作用更明显。

2.利尿剂+β受体阻滞剂

①利尿剂激活肾素,增快心率的作用可被β-阻滞剂抵消;

②β受体阻滞剂缩血管及促肾潴钠作用被噻嗪类利尿剂所抵消。

3.β受体阻滞剂+CCB(钙离子拮抗剂)

β受体阻滞剂有减慢心率的作用,而双氢吡啶类的钙离子拮抗剂可以反射性的加快心率。

4.CCB+ ACEI/ARB

CCB和ACEI,作用机理完全不同,可以联合使用。

5. β受体阻滞剂+α受体阻滞剂

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2039768, encodeId=e1cf2039e6828, content=<a href='/topic/show?id=bf0f5584ef6' target=_blank style='color:#2F92EE;'>#抗高血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55847, encryptionId=bf0f5584ef6, topicName=抗高血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87531, createdName=klivis, createdTime=Thu Nov 02 13:53:00 CST 2017, time=2017-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2027102, encodeId=5a08202e102b5, content=<a href='/topic/show?id=5dd1558503e' target=_blank style='color:#2F92EE;'>#抗高血压药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55850, encryptionId=5dd1558503e, topicName=抗高血压药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=362b271, createdName=zexyw01, createdTime=Mon Jul 24 06:53:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=168696, encodeId=fbf7168696c1, content=要根据药代与药效来决定怎么用, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160813/IMG57AE8D930B40D3563.jpg, createdBy=13a81695880, createdName=xmax889, createdTime=Sat Jan 07 23:51:00 CST 2017, time=2017-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=168284, encodeId=6b4e16828416, content=谢谢了,很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Fri Jan 06 09:02:07 CST 2017, time=2017-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=168244, encodeId=9ece1682441a, content=谢谢了,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Fri Jan 06 06:51:00 CST 2017, time=2017-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=168243, encodeId=82271682437c, content=谢谢了,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Fri Jan 06 06:50:45 CST 2017, time=2017-01-06, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2039768, encodeId=e1cf2039e6828, content=<a href='/topic/show?id=bf0f5584ef6' target=_blank style='color:#2F92EE;'>#抗高血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55847, encryptionId=bf0f5584ef6, topicName=抗高血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87531, createdName=klivis, createdTime=Thu Nov 02 13:53:00 CST 2017, time=2017-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2027102, encodeId=5a08202e102b5, content=<a href='/topic/show?id=5dd1558503e' target=_blank style='color:#2F92EE;'>#抗高血压药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55850, encryptionId=5dd1558503e, topicName=抗高血压药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=362b271, createdName=zexyw01, createdTime=Mon Jul 24 06:53:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=168696, encodeId=fbf7168696c1, content=要根据药代与药效来决定怎么用, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160813/IMG57AE8D930B40D3563.jpg, createdBy=13a81695880, createdName=xmax889, createdTime=Sat Jan 07 23:51:00 CST 2017, time=2017-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=168284, encodeId=6b4e16828416, content=谢谢了,很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Fri Jan 06 09:02:07 CST 2017, time=2017-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=168244, encodeId=9ece1682441a, content=谢谢了,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Fri Jan 06 06:51:00 CST 2017, time=2017-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=168243, encodeId=82271682437c, content=谢谢了,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Fri Jan 06 06:50:45 CST 2017, time=2017-01-06, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2039768, encodeId=e1cf2039e6828, content=<a href='/topic/show?id=bf0f5584ef6' target=_blank style='color:#2F92EE;'>#抗高血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55847, encryptionId=bf0f5584ef6, topicName=抗高血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87531, createdName=klivis, createdTime=Thu Nov 02 13:53:00 CST 2017, time=2017-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2027102, encodeId=5a08202e102b5, content=<a href='/topic/show?id=5dd1558503e' target=_blank style='color:#2F92EE;'>#抗高血压药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55850, encryptionId=5dd1558503e, topicName=抗高血压药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=362b271, createdName=zexyw01, createdTime=Mon Jul 24 06:53:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=168696, encodeId=fbf7168696c1, content=要根据药代与药效来决定怎么用, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160813/IMG57AE8D930B40D3563.jpg, createdBy=13a81695880, createdName=xmax889, createdTime=Sat Jan 07 23:51:00 CST 2017, time=2017-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=168284, encodeId=6b4e16828416, content=谢谢了,很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Fri Jan 06 09:02:07 CST 2017, time=2017-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=168244, encodeId=9ece1682441a, content=谢谢了,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Fri Jan 06 06:51:00 CST 2017, time=2017-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=168243, encodeId=82271682437c, content=谢谢了,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Fri Jan 06 06:50:45 CST 2017, time=2017-01-06, status=1, ipAttribution=)]
    2017-01-07 xmax889

    要根据药代与药效来决定怎么用

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2039768, encodeId=e1cf2039e6828, content=<a href='/topic/show?id=bf0f5584ef6' target=_blank style='color:#2F92EE;'>#抗高血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55847, encryptionId=bf0f5584ef6, topicName=抗高血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87531, createdName=klivis, createdTime=Thu Nov 02 13:53:00 CST 2017, time=2017-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2027102, encodeId=5a08202e102b5, content=<a href='/topic/show?id=5dd1558503e' target=_blank style='color:#2F92EE;'>#抗高血压药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55850, encryptionId=5dd1558503e, topicName=抗高血压药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=362b271, createdName=zexyw01, createdTime=Mon Jul 24 06:53:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=168696, encodeId=fbf7168696c1, content=要根据药代与药效来决定怎么用, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160813/IMG57AE8D930B40D3563.jpg, createdBy=13a81695880, createdName=xmax889, createdTime=Sat Jan 07 23:51:00 CST 2017, time=2017-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=168284, encodeId=6b4e16828416, content=谢谢了,很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Fri Jan 06 09:02:07 CST 2017, time=2017-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=168244, encodeId=9ece1682441a, content=谢谢了,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Fri Jan 06 06:51:00 CST 2017, time=2017-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=168243, encodeId=82271682437c, content=谢谢了,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Fri Jan 06 06:50:45 CST 2017, time=2017-01-06, status=1, ipAttribution=)]
    2017-01-06 明月清辉

    谢谢了,很好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2039768, encodeId=e1cf2039e6828, content=<a href='/topic/show?id=bf0f5584ef6' target=_blank style='color:#2F92EE;'>#抗高血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55847, encryptionId=bf0f5584ef6, topicName=抗高血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87531, createdName=klivis, createdTime=Thu Nov 02 13:53:00 CST 2017, time=2017-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2027102, encodeId=5a08202e102b5, content=<a href='/topic/show?id=5dd1558503e' target=_blank style='color:#2F92EE;'>#抗高血压药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55850, encryptionId=5dd1558503e, topicName=抗高血压药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=362b271, createdName=zexyw01, createdTime=Mon Jul 24 06:53:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=168696, encodeId=fbf7168696c1, content=要根据药代与药效来决定怎么用, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160813/IMG57AE8D930B40D3563.jpg, createdBy=13a81695880, createdName=xmax889, createdTime=Sat Jan 07 23:51:00 CST 2017, time=2017-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=168284, encodeId=6b4e16828416, content=谢谢了,很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Fri Jan 06 09:02:07 CST 2017, time=2017-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=168244, encodeId=9ece1682441a, content=谢谢了,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Fri Jan 06 06:51:00 CST 2017, time=2017-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=168243, encodeId=82271682437c, content=谢谢了,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Fri Jan 06 06:50:45 CST 2017, time=2017-01-06, status=1, ipAttribution=)]
    2017-01-06 txqjm

    谢谢了,学习了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2039768, encodeId=e1cf2039e6828, content=<a href='/topic/show?id=bf0f5584ef6' target=_blank style='color:#2F92EE;'>#抗高血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55847, encryptionId=bf0f5584ef6, topicName=抗高血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87531, createdName=klivis, createdTime=Thu Nov 02 13:53:00 CST 2017, time=2017-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2027102, encodeId=5a08202e102b5, content=<a href='/topic/show?id=5dd1558503e' target=_blank style='color:#2F92EE;'>#抗高血压药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55850, encryptionId=5dd1558503e, topicName=抗高血压药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=362b271, createdName=zexyw01, createdTime=Mon Jul 24 06:53:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=168696, encodeId=fbf7168696c1, content=要根据药代与药效来决定怎么用, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160813/IMG57AE8D930B40D3563.jpg, createdBy=13a81695880, createdName=xmax889, createdTime=Sat Jan 07 23:51:00 CST 2017, time=2017-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=168284, encodeId=6b4e16828416, content=谢谢了,很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Fri Jan 06 09:02:07 CST 2017, time=2017-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=168244, encodeId=9ece1682441a, content=谢谢了,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Fri Jan 06 06:51:00 CST 2017, time=2017-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=168243, encodeId=82271682437c, content=谢谢了,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Fri Jan 06 06:50:45 CST 2017, time=2017-01-06, status=1, ipAttribution=)]
    2017-01-06 txqjm

    谢谢了,学习了

    0

相关资讯

Am J Cardiovasc Drugs:长期抗高血压治疗与卒中预防:荟萃分析

背景:每年卒中引起世界范围内约670万人死亡,是引起死亡的第二大疾病。高血压是卒中独立的危险因素,高血压药物治疗能显著降低卒中的发生率。虽然先前荟萃分析表明:一些抗高血压药物在降低卒中风险方面优于安慰剂,但是具体哪类药物是最有效的尚不清楚。方法:我们在MEDLINE进行系统性搜索1999年到2014年发表的抗高血压药物治疗对卒中一级和或二级预防的随机对照试验(RCT)的文章。五类抗高血压药物为:A

Hypertension:慢性肾病患者难治性高血压的发生率较高,预后不好

慢性肾脏病患者中难治性高血压(ATRH)和临床结果的关系尚未研究清楚。研究者分析慢性肾功能不全队列研究(CRIC)中3367名高血压患者的数据,确定非透析慢性肾病患者ATRH的发生率,相关性及临床预后。ATRH的定义为应用三种及三种以上的抗高血压药血压≥140/90mmHg,或者基线时,应用四种及四种以上的抗高血压的药,才能维持血压在目标值。ATRH的发生率为40.4%。高龄,男性,黑人,糖尿病,

Neurology:这些抗高血压药物还能降低痴呆风险,你知道吗?

抗高血压药使用和血压变化的痴呆风险如何呢?2016年8月,发表在《Neurology》的一项队列研究对此进行分析。结果表明,非二氢吡啶类钙通道阻滞剂和髓袢利尿剂与痴呆风险的降低相关,独立于CV-BPV。目的:旨在确定在过去的4年,离散性抗高血压药物类别和痴呆发生之间的关系,并控制了血压变化(BPV)。方法:总共6537名来自于前瞻性基于人群队列中的参与者(平均79岁,62%为女性)随访了痴呆发生。

Baidu
map
Baidu
map
Baidu
map